AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
CHARLOTTETOWN, P.E.I. -- Although nonsteroidal anti-inflammatory drugs are currently the first-line treatment for primary dysmenorrhea, physicians should consider replacing them with cyclooxygenase-2 inhibitors, advised Dr. Fay Weisberg of the University of Toronto.
"COX-2 inhibitors are a new addition to the management of primary dysmenorrhea. They work as well as traditional NSAIDs but have a faster onset of action and potentially less side effects," Dr. Weisberg said at the annual clinical meeting of the Society of Obstetricians and Gynaecologists of Canada.
Studies show that NSAIDs provide effective pain relief in 64%-100% of patients with primary dysmenorrhea. But their main side effect, gastrointestinal intolerability, makes them difficult for some patients to take, even on a very short-term basis, and multiple dosing is also problematic, she said.
Even 1 week of NSAID use has been associated with GI ulcers, and the risk of GI ...
Source: HighBeam Research, COX-2 inhibitors advocated for dysmenorrhea: expert...